“Pain relief is a billiondollar market, and drug companies have no incentive to fund trials that would reduce patients’ dependence on their products, he points out. And neither have medical insurers, because if medical costs come down, so do their profits. The trouble with hypnosis and other psychological therapies, he says, is that “there’s no intervening industry that has the interest in pushing it.”
